Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pang

Showing results (771-780 of 824) with videos related to

Pageof 83
Sort By:
Brain, Behavior, & Immunity - Health|April 1, 2025
Associations between the neural-hematopoietic-inflammatory axis and DNA methylation of stress-related genes in human leukocytes: Data from the Washington, D.C. cardiovascular health and needs assessmentManuel A Cintron, Yvonne Baumer, Alina P S Pang, et al.
The New England Journal of Medicine|April 15, 2014
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infectionNezam Afdhal, Stefan Zeuzem, Paul Kwo, et al.
JACC. Heart Failure|November 15, 2020
Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2Rahul S Loungani, John R Teerlink, Marco Metra, et al.
Journal of Hepatology|June 8, 2023
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trialsEd Gane, Young-Suk Lim, Jae B Kim, et al.
The Journal of Infectious Diseases|August 14, 2025
Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People Living with HIVLishomwa C Ndhlovu, Leila B Giron, Juliana Galinskas, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
European Journal of Heart Failure|April 1, 2010
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care MedicineMihai Gheorghiade, Ferenc Follath, Piotr Ponikowski, et al.
Hepatology International|May 21, 2016
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virusYoung-Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, et al.
ESC Heart Failure|May 15, 2020
Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failureArzu Kalayci, W Frank Peacock, John T Nagurney, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
Pageof 83

Showing results (771-780 of 824) with videos related to

Sort By:
Pageof 83
Brain, Behavior, & Immunity - Health|April 1, 2025
Associations between the neural-hematopoietic-inflammatory axis and DNA methylation of stress-related genes in human leukocytes: Data from the Washington, D.C. cardiovascular health and needs assessmentManuel A Cintron, Yvonne Baumer, Alina P S Pang, et al.
The New England Journal of Medicine|April 15, 2014
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infectionNezam Afdhal, Stefan Zeuzem, Paul Kwo, et al.
JACC. Heart Failure|November 15, 2020
Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2Rahul S Loungani, John R Teerlink, Marco Metra, et al.
Journal of Hepatology|June 8, 2023
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trialsEd Gane, Young-Suk Lim, Jae B Kim, et al.
The Journal of Infectious Diseases|August 14, 2025
Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People Living with HIVLishomwa C Ndhlovu, Leila B Giron, Juliana Galinskas, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
European Journal of Heart Failure|April 1, 2010
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care MedicineMihai Gheorghiade, Ferenc Follath, Piotr Ponikowski, et al.
Hepatology International|May 21, 2016
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-naïve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virusYoung-Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, et al.
ESC Heart Failure|May 15, 2020
Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failureArzu Kalayci, W Frank Peacock, John T Nagurney, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
Pageof 83